Table of Contents

July 1, 2023; Volume 64,Issue 7

  1. Dixit, Manish

    1. Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
      Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1001-1008; DOI: https://doi.org/10.2967/jnumed.123.265594

  2. Dreher, Niklas

    1. Open Access
      Theranostics in Hematooncology
      Andreas K. Buck, Sebastian E. Serfling, Sabrina Kraus, Samuel Samnick, Niklas Dreher, Takahiro Higuchi, Leo Rasche, Hermann Einsele and Rudolf A. Werner
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1009-1016; DOI: https://doi.org/10.2967/jnumed.122.265199

  3. Du, Yong

    1. The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
      Open Access
      The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
      Jan Taprogge, Carla Abreu, Siraj Yusuf, Gemma Ainsworth, Rachel H. Phillip, Jonathan I. Gear, Rebecca Gregory, Francesca Leek, Iain Murray, Amy B. Coulson, Sarah R. Brown, Yong Du, Kate Newbold, Jonathan Wadsley and Glenn D. Flux
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1125-1130; DOI: https://doi.org/10.2967/jnumed.122.264913

  4. Duan, Zhijian

    1. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
      Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
      Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke and Freddy E. Escorcia
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1017-1023; DOI: https://doi.org/10.2967/jnumed.122.265171

  5. Eiber, Matthias

    1. PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
      PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
      Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1024-1029; DOI: https://doi.org/10.2967/jnumed.122.265242
    2. Delayed Imaging Improves Lesion Detectability in [<sup>99m</sup>Tc]Tc-PSMA-I&amp;S SPECT/CT in Recurrent Prostate Cancer
      Delayed Imaging Improves Lesion Detectability in [99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
      Christoph Berliner, Lisa Steinhelfer, Maythinee Chantadisai, Markus Kroenke, Daniel Koehler, Randi Pose, Peter Bannas, Sophie Knipper, Matthias Eiber and Tobias Maurer
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1036-1042; DOI: https://doi.org/10.2967/jnumed.122.265252

  6. Einsele, Hermann

    1. Open Access
      Theranostics in Hematooncology
      Andreas K. Buck, Sebastian E. Serfling, Sabrina Kraus, Samuel Samnick, Niklas Dreher, Takahiro Higuchi, Leo Rasche, Hermann Einsele and Rudolf A. Werner
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1009-1016; DOI: https://doi.org/10.2967/jnumed.122.265199

  7. Emmett, Louise

    1. PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
      PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
      Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1024-1029; DOI: https://doi.org/10.2967/jnumed.122.265242
    2. <sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
      68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
      Riccardo Mei, Lukas Kessler, Kim M. Pabst, Manuel Weber, Christian Schmidkonz, Christoph Rischpler, Helle Damgaard Zacho, Thomas Hope, Sarah M. Schwarzenböck, Martin Allen-Auerbach, Louise Emmett, Justin Ferdinandus, Marcus Unterrainer, Benedikt M. Schaarschmidt, Lale Umutlu, Andrea Farolfi, Paolo Castellucci, Cristina Nanni, Silvi Telo, Stefano Fanti, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1043-1048; DOI: https://doi.org/10.2967/jnumed.122.265245

  8. Escorcia, Freddy E.

    1. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
      Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
      Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke and Freddy E. Escorcia
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1017-1023; DOI: https://doi.org/10.2967/jnumed.122.265171

  9. Esfahani, Shadi A.

    1. Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
      Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
      Shadi A. Esfahani, Carolina De Aguiar Ferreira, Priska Summer, Umar Mahmood and Pedram Heidari
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1056-1061; DOI: https://doi.org/10.2967/jnumed.123.265391

  10. Even-sapir, Einat

    1. Staging Prostate Cancer with <sup>68</sup>Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
      Open Access
      Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
      Mikhail Kesler, Dan Cohen, Charles Levine, David Sarid, Daniel Keizman, Ofer Yossepowitch and Einat Even-Sapir
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1030-1035; DOI: https://doi.org/10.2967/jnumed.122.265371
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 26) Next »
Back to top

In this issue